A possible effect of montelukast on neurological aging examined by the use of register data

Abstract Background The leukotriene receptor antagonist montelukast has been shown to rejuvenate aged brains in rats; however, data on humans are still scarce. Objective To investigate if montelukast may alleviate degenerative neurological changes using a register data. Setting Norwegian registry da...

Full description

Bibliographic Details
Published in:International Journal of Clinical Pharmacy
Main Authors: Grinde, Bjørn, Schirmer, Henrik, Eggen, Anne Elise, Aigner, Ludwig, Engdahl, Bo
Other Authors: Norwegian Institute of Public Health
Format: Article in Journal/Newspaper
Language:English
Published: Springer Science and Business Media LLC 2020
Subjects:
Online Access:http://dx.doi.org/10.1007/s11096-020-01160-8
https://link.springer.com/content/pdf/10.1007/s11096-020-01160-8.pdf
https://link.springer.com/article/10.1007/s11096-020-01160-8/fulltext.html
id crspringernat:10.1007/s11096-020-01160-8
record_format openpolar
spelling crspringernat:10.1007/s11096-020-01160-8 2023-05-15T18:34:39+02:00 A possible effect of montelukast on neurological aging examined by the use of register data Grinde, Bjørn Schirmer, Henrik Eggen, Anne Elise Aigner, Ludwig Engdahl, Bo Norwegian Institute of Public Health 2020 http://dx.doi.org/10.1007/s11096-020-01160-8 https://link.springer.com/content/pdf/10.1007/s11096-020-01160-8.pdf https://link.springer.com/article/10.1007/s11096-020-01160-8/fulltext.html en eng Springer Science and Business Media LLC https://creativecommons.org/licenses/by/4.0 https://creativecommons.org/licenses/by/4.0 CC-BY International Journal of Clinical Pharmacy volume 43, issue 3, page 541-548 ISSN 2210-7703 2210-7711 Pharmacology (medical) Pharmaceutical Science Pharmacology Toxicology Pharmacy journal-article 2020 crspringernat https://doi.org/10.1007/s11096-020-01160-8 2022-01-14T15:34:11Z Abstract Background The leukotriene receptor antagonist montelukast has been shown to rejuvenate aged brains in rats; however, data on humans are still scarce. Objective To investigate if montelukast may alleviate degenerative neurological changes using a register data. Setting Norwegian registry data analyses. Method The present observational study was based on data from the Norwegian Prescription Database and the Tromsø Study. The former has information regarding the use of prescription medicine; the latter includes tests for brain function such as subjective memory and finger-tapping. Multivariate linear regression analyses were performed to see how the use of various medications correlated with the test results, correcting for likely confounders. Main outcome measure Results on seven different tests considered relevant for neurological health were used as outcome. Results Previous use of montelukast correlated with improved scores on cognitive or neurological functioning (F = 2.20, p = 0.03 in a multivariate test). A range of other medications were tested with the same algorithm, including drugs acting on the immune system, but none of them correlated with (overall) significantly improved test results. Conclusion The present data suggest that montelukast may alleviate degenerative neurological changes associated with human aging. Article in Journal/Newspaper Tromsø Springer Nature (via Crossref) Tromsø International Journal of Clinical Pharmacy 43 3 541 548
institution Open Polar
collection Springer Nature (via Crossref)
op_collection_id crspringernat
language English
topic Pharmacology (medical)
Pharmaceutical Science
Pharmacology
Toxicology
Pharmacy
spellingShingle Pharmacology (medical)
Pharmaceutical Science
Pharmacology
Toxicology
Pharmacy
Grinde, Bjørn
Schirmer, Henrik
Eggen, Anne Elise
Aigner, Ludwig
Engdahl, Bo
A possible effect of montelukast on neurological aging examined by the use of register data
topic_facet Pharmacology (medical)
Pharmaceutical Science
Pharmacology
Toxicology
Pharmacy
description Abstract Background The leukotriene receptor antagonist montelukast has been shown to rejuvenate aged brains in rats; however, data on humans are still scarce. Objective To investigate if montelukast may alleviate degenerative neurological changes using a register data. Setting Norwegian registry data analyses. Method The present observational study was based on data from the Norwegian Prescription Database and the Tromsø Study. The former has information regarding the use of prescription medicine; the latter includes tests for brain function such as subjective memory and finger-tapping. Multivariate linear regression analyses were performed to see how the use of various medications correlated with the test results, correcting for likely confounders. Main outcome measure Results on seven different tests considered relevant for neurological health were used as outcome. Results Previous use of montelukast correlated with improved scores on cognitive or neurological functioning (F = 2.20, p = 0.03 in a multivariate test). A range of other medications were tested with the same algorithm, including drugs acting on the immune system, but none of them correlated with (overall) significantly improved test results. Conclusion The present data suggest that montelukast may alleviate degenerative neurological changes associated with human aging.
author2 Norwegian Institute of Public Health
format Article in Journal/Newspaper
author Grinde, Bjørn
Schirmer, Henrik
Eggen, Anne Elise
Aigner, Ludwig
Engdahl, Bo
author_facet Grinde, Bjørn
Schirmer, Henrik
Eggen, Anne Elise
Aigner, Ludwig
Engdahl, Bo
author_sort Grinde, Bjørn
title A possible effect of montelukast on neurological aging examined by the use of register data
title_short A possible effect of montelukast on neurological aging examined by the use of register data
title_full A possible effect of montelukast on neurological aging examined by the use of register data
title_fullStr A possible effect of montelukast on neurological aging examined by the use of register data
title_full_unstemmed A possible effect of montelukast on neurological aging examined by the use of register data
title_sort possible effect of montelukast on neurological aging examined by the use of register data
publisher Springer Science and Business Media LLC
publishDate 2020
url http://dx.doi.org/10.1007/s11096-020-01160-8
https://link.springer.com/content/pdf/10.1007/s11096-020-01160-8.pdf
https://link.springer.com/article/10.1007/s11096-020-01160-8/fulltext.html
geographic Tromsø
geographic_facet Tromsø
genre Tromsø
genre_facet Tromsø
op_source International Journal of Clinical Pharmacy
volume 43, issue 3, page 541-548
ISSN 2210-7703 2210-7711
op_rights https://creativecommons.org/licenses/by/4.0
https://creativecommons.org/licenses/by/4.0
op_rightsnorm CC-BY
op_doi https://doi.org/10.1007/s11096-020-01160-8
container_title International Journal of Clinical Pharmacy
container_volume 43
container_issue 3
container_start_page 541
op_container_end_page 548
_version_ 1766219503919693824